- $75.34m
- $104.47m
- $0.06m
Brief: Meridian Bioscience Reports Q4 results
Meridian Bioscience Inc expected to post earnings of 15cents a share - Earnings Preview
Brief: Tembo Announces Definitive Agreement To Supply Ev Conversion Kits
Provides Notification On Continued Listing Requirement
Brief: Meridian Bioscience Says Obtained Merger Approval For All Relevant Antitrust And FDI Filings Except For Filing Related To CFIUS
U.S. STOCKS ON THE MOVE-Energy firms, Retail chatter, MoneyGram
U.S. STOCKS ON THE MOVE-Big banks, Beyond Meat, Cinemark
Meridian Bioscience falls after swinging to loss in Q3
Brief: Meridian Bioscience Inc Reports Q3 Net Loss Per Basic Common Share Of $0.17
Brief: Meridian Bioscience Receives Re-Authorization From FDA For Its Revogene® Sars-Cov-2 Molecular Assay
Brief: Vivopower International PLC Announces Pricing Of $5.5 Million Registered Direct Offering
Brief: Meridian Says If Deal Is Terminated Under Certain Circumstances, Co Will Be Obligated To Pay To Columbus Holding A Termination Fee $45.96 Million In Cash
Meridian down on $1.53 bln take-private deal
South Korean firms to take Meridian Bioscience private in $1.53 bln deal (updated)
NASDAQ RESUMED AT 07:45 AM
South Korean consortium to buy Meridian Bioscience in $1.53 bln deal
Brief: Meridian Bioscience Enters Into Agreement To Be Acquired By SD Biosensor And SJL Partners In $1.53 Bln Deal
Brief: Meridian Bioscience Announces Preliminary Results For Fiscal 2022 Third Quarter
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:03 AM